We studied 17 patients with severe systemic necrotizing vasculitis over an 11-year-period. Sixteen patients were treated daily with cyclophosphamide (2 mg per kilogram per day), and one was treated with azathioprine (2 mg per kilogram per day). Before entering the study, all patients had active and progressive disease, even though 16 patients had been receiving corticosteroids that had caused severe and often incapacitating toxic side effects. Three patients died during the study. Complete and often dramatic remissions occurred in the surviving 14 patients, who were then placed on alternate-day corticosteroid treatment with continuation of cyclophosphamide. Corticosteroids were later discontinued in seven patients. The mean duration of remission was 22 months (range, two to 61). No patient showed recurrence of disease during treatment with cytotoxic agents.
This article has been cited by other articles:
Flossmann, O, Baslund, B, Bruchfeld, A, Cohen Tervaert, J W, Hall, C, Heinzel, P, Hellmich, B, Luqmani, R A, Nemoto, K, Tesar, V, Jayne, D R W
(2009). Deoxyspergualin in relapsing and refractory Wegener's granulomatosis. Ann Rheum Dis
68: 1125-1130
[Abstract][Full Text]
Wang, Q.-q., Qiu, Y.-g., Zhu, Y.-j., Zhu, J.-h., Wang, L.-h., Hu, X.-s., Hu, S.-j., Zheng, L.-r., Tao, Q.-m., Zhang, F.-r., Zhang, Y.
(2009). Cyclophosphamide protects against myocardial ischemia/reperfusion injury in rats: One of the therapeutic targets is high sensitivity C-reactive protein. J. Thorac. Cardiovasc. Surg.
137: 991-996
[Abstract][Full Text]
van Rossum, A. P, Huitema, M. G, Stegeman, C. A, Bijl, M., de Leeuw, K., Van Leeuwen, M. A, Limburg, P. C, Kallenberg, C. G M
(2007). Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls. Ann Rheum Dis
66: 1350-1355
[Abstract][Full Text]
Joy, M. S., Hogan, S. L., Jennette, J. C., Falk, R. J., Nachman, P. H.
(2005). A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrol Dial Transplant
20: 2725-2732
[Abstract][Full Text]
Shuster, T. A., Almeida, J., Coats, R., Kalra, A., Silver, D.
(2004). Gastrointestinal Bleeding as the Initial Manifestation of a Polyarteritis Nodosa-Associated Hepatic Artery Aneurysm-Duodenal Fistula: A Case Report. VASC ENDOVASCULAR SURG
38: 563-568
[Abstract]
Jayne, D., Rasmussen, N., Andrassy, K., Bacon, P., Tervaert, J. W. C., Dadoniene, J., Ekstrand, A., Gaskin, G., Gregorini, G., de Groot, K., Gross, W., Hagen, E. C., Mirapeix, E., Pettersson, E., Siegert, C., Sinico, A., Tesar, V., Westman, K., Pusey, C., the European Vasculitis Study Group,
(2003). A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies. NEJM
349: 36-44
[Abstract][Full Text]
Tarhan, N. C., Coskun, M., Kayahan, E. M., Yildirim, E., Yucel, E.
(2003). Regression of Abdominal Visceral Aneurysms in Polyarteritis Nodosa: CT Findings. Am. J. Roentgenol.
180: 1617-1619
[Full Text]
Hoi, A. Y., Morand, E. F.
(2003). Churg-Strauss syndrome: the use of cyclophosphamide in mononeuritis. Rheumatology (Oxford)
42: 390-391
[Full Text]
Nachman, P. H., Martin, J.
(2002). Developments in the Immunotherapy of Glomerular Disease. Journal of Pharmacy Practice
15: 472-489
[Abstract]
Hidalgo-Tenorio, C, Sabio, J M, Jimenez-Alonso, J
(2002). Alopecia in Wegener's granulomatosis. Ann Rheum Dis
61: 654-655
[Full Text]
Kandeel, A.'a., Ramesh, S., Chen, Y., Celik, C., Jenis, E., Ambrus, J. L. Jr
(2000). Microscopic Polyangiitis in a Pediatric Patient. Arch Fam Med
9: 1189-1192
[Abstract][Full Text]
Brogan, P A, Dillon, M J
(2000). Personal practice: The use of immunosuppressive and cytotoxic drugs in non-malignant disease. Arch. Dis. Child.
83: 259-264
[Full Text]
Carruthers, D. M., Connor, S., Howie, A. J., Exley, A. R., Raza, K., Bacon, P. A., Guest, P.
(2000). Percutaneous image-guided biopsy of lung nodules in the assessment of disease activity in Wegener's granulomatosis. Rheumatology (Oxford)
39: 776-782
[Abstract][Full Text]
Jayne, D.
(2000). Evidence-based treatment of systemic vasculitis. Rheumatology (Oxford)
39: 585-595
[Full Text]
NOWACK, R., GÖBEL, U., KLOOKER, P., HERGESELL, O., ANDRASSY, K., VAN DER WOUDE, F. J.
(1999). Mycophenolate Mofetil for Maintenance Therapy of Wegener's Granulomatosis and Microscopic Polyangiitis: A Pilot Study in 11 Patients with RenalInvolvement. J. Am. Soc. Nephrol.
10: 1965-1971
[Abstract][Full Text]
Lhote, F, Cohen, P, Guillevin, L
(1998). Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus
7: 238-258
[Abstract]
Martin-Suarez, I., D'Cruz, D., Mansoor, M., Fernandes, A. P., Khamashta, M. A, Hughes, G. R V
(1997). Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann Rheum Dis
56: 481-487
[Abstract][Full Text]
Ledford, D. K.
(1992). Immunologic Aspects of Cardiovascular Disease. JAMA
268: 2923-2929
[Abstract]
Fries, J. F.
(1989). Advances in Management of Rheumatic Disease: 1965 to 1985. Arch Intern Med
149: 1002-1011
[Abstract]
Dahlberg, P. J., Lockhart, J. M., Overholt, E. L.
(1989). Diagnostic Studies for Systemic Necrotizing Vasculitis: Sensitivity, Specificity, and Predictive Value in Patients With Multisystem Disease. Arch Intern Med
149: 161-165
[Abstract]
Ledford, D. K., Espinoza, L. R.
(1987). Immunologic Aspects of Cardiovascular Disease. JAMA
258: 2974-2982
[Abstract]
Myers, L. W., Fahey, J. L., Moody, D. J., Mickey, M. R., Frane, M. V., Ellison, G. W.
(1987). Cyclophosphamide 'Pulses' in Chronic Progressive Multiple Sclerosis: A Preliminary Clinical Trial. Arch Neurol
44: 828-832
[Abstract]
Kinyoun, J. L., Kalina, R. E., Klein, M. L.
(1987). Choroidal Involvement in Systemic Necrotizing Vasculitis. Arch Ophthalmol
105: 939-942
[Abstract]
Stein, R. L., Martino, C. R., Weinert, D. M., Hueftle, M., Kammer, G. M.
(1987). Cerebral Angiography as a Guide for Therapy in Isolated Central Nervous System Vasculitis. JAMA
257: 2193-2195
[Abstract]
Ringel, S. P., Carry, M. R., Aguilera, A. J., Starcevich, J. M.
(1986). Quantitative Histopathology of the Inflammatory Myopathies. Arch Neurol
43: 1004-1009
[Abstract]
Berman, R. S., Silvestri, D. L.
(1986). Dermatologic Problems in the Intensive Care Unit: Part IV. J Intensive Care Med
1: 224-239
[Abstract]
SHELHAMER, J. H., VOLKMAN, D. J., PARRILLO, J. E., LAWLEY, T. J., JOHNSTON, M. R., FAUCI, A. S.
(1985). Takayasu's Arteritis and Its Therapy. ANN INTERN MED
103: 121-126
[Abstract]
O'Connell, M. T., Kubrusly, D. B., Fournier, A. M.
(1985). Systemic Necrotizing Vasculitis Seen Initially as Hypertensive Crisis. Arch Intern Med
145: 265-267
[Abstract]
JAMES, S. P., HOOFNAGLE, J. H., STROBER, W., JONES, E. A.
(1983). Primary Biliary Cirrhosis: A Model Autoimmune Disease. ANN INTERN MED
99: 500-512
[Abstract]
Weinstein, J. M., Chui, H., Lane, S., Corbett, J., Towfighi, J.
(1983). Churg-Strauss Syndrome (Allergic Granulomatous Angiitis) Neuro-ophthalmologic Manifestations. Arch Ophthalmol
101: 1217-1220
[Abstract]
NEPHROLOGY COMMITTEE,
(1983). Nephrology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers. ANN INTERN MED
98: 563-568
[Abstract]
Goslen, J. B., Graham, W., Lazarus, G. S.
(1983). Cutaneous Polyarteritis Nodosa: Report of a Case Associated With Crohn's Disease. Arch Dermatol
119: 326-329
[Abstract]
(1983). Rheumatology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers. ANN INTERN MED
98: 264-269
[Abstract]
Fink, J. N., Fauci, A.
(1982). Immunologic Aspects of Cardiovascular Disease. JAMA
248: 2716-2721
[Abstract]
Gehr, M. K., Chopra, S., Chung, T. J., Hamburger, R. J.
(1982). Polyarteritis Nodosa After HBsAg Hepatitis in a Patient Undergoing Hemodialysis: Manifestation and Response to Therapy. Arch Intern Med
142: 1554-1556
[Abstract]
BACON, A. M., ROSENBERG, S. A.
(1982). Cyclophosphamide Hepatotoxicity in a Patient with Systemic Lupus Erythematosus. ANN INTERN MED
97: 62-63
[Abstract]
Cupps, T. R., Springer, R. M., Fauci, A. S.
(1982). Chronic, Recurrent Small-Vessel Cutaneous Vasculitis: Clinical Experience in 13 Patients. JAMA
247: 1994-1998
[Abstract]
Vazquez, J.J., San Martin, P., Barbado, F.J., Gil, A., Guerra, J., Arnalich, F., Garcia Puig, J., Sanchez Mejias, F.
(1981). Angiographic Findings in Systemic Necrotizing Vasculitis. ANGIOLOGY
32: 773-779
WHEELER, G. E.
(1981). Cyclophosphamide-Associated Leukemia in Wegener's Granulomatosis. ANN INTERN MED
94: 361-362
[Abstract]
WHITE, R. H., SCHAMBELAN, M.
(1981). Hypertension and Angiographic Findings in Necrotizing Vasculitis. ANN INTERN MED
94: 410-411
[Abstract]
Bocanegra, T., Vasey, F. B., Espinoza, L. R., Germain, B. F.
(1980). Pancreatic Pseudocyst: A Complication of Necrotizing Vasculitis (Polyarteritis Nodosa). Arch Intern Med
140: 1359-1361
[Abstract]
ABEL, T., ANDREWS, B. S., CUNNINGHAM, P. H., BRUNNER, C. M., DAVIS, J. S. IV, HORWITZ, D. A.
(1980). Rheumatoid Vasculitis: Effect of Cyclophosphamide on the Clinical Course and Levels of Circulating Immune Complexes. ANN INTERN MED
93: 407-413
[Abstract]
LEJONC, J. L., MACQUIN, I., BROCHARD, P., SCHAEFFER, A.
(1980). Hypertension in Systemic Necrotizing Vasculitis. ANN INTERN MED
93: 150-150
[Abstract]
(1980). Cyclophosphamide May Be Effective in Severe Vasculitis. JAMA
243: 520-520
Previous
